24 May 2010

Treatment With Rituxan May Reduce Recurrence of Follicular Lymphoma

Research also finds Revlimid slows progression of multiple myeloma

This article has not necessarily been edited by Health24.

The researchers reached their conclusions after randomly assigning patients with follicular lymphoma to two years of treatment with the drug (505 patients) or no treatment with the drug (513 patients).


Read Health24’s Comments Policy

Comment on this story
Comments have been closed for this article.

Ask the Expert

Cancer expert

CANSA’s purpose is to lead the fight against cancer in South Africa. Its mission is to be the preferred non-profit organisation that enables research, educates the public and provides support to all people affected by cancer. Questions are answered by CANSA’s Head of Health Professor Michael Herbst. For more information, visit

Still have a question?

Get free advice from our panel of experts

The information provided does not constitute a diagnosis of your condition. You should consult a medical practitioner or other appropriate health care professional for a physical exmanication, diagnosis and formal advice. Health24 and the expert accept no responsibility or liability for any damage or personal harm you may suffer resulting from making use of this content.

* You must accept our condition

Forum Rules